Ajay Narasimha
Senior vice president of corporate strategy and business development at Mirum Pharmaceuticals, a scientist-turned-commercial executive involved in BD deals and rare disease portfolio strategy.
Best podcasts with Ajay Narasimha
Ranked by the Snipd community
7 snips
Feb 3, 2026 • 15min
How Mirum is Advancing Rare Disease Care Through Strategic M&A (Sponsored)
Ajay Narasimha, Mirum Pharmaceuticals SVP of corporate strategy and business development and scientist-turned-commercial exec, discusses Mirum’s first acquisition of Bluejay and why brelovitug targets a critical unmet need in hepatitis delta virus. He outlines how the deal fits Mirum’s rare liver disease strategy, upcoming registrational readouts, and the company’s approach to patient-centric dealmaking and pipeline building.
